PEPCK-M Activators

Common PEPCK-M Activators include, but are not limited to Dexamethasone CAS 50-02-2, Forskolin CAS 66575-29-9, Retinoic Acid, all trans CAS 302-79-4, Rosiglitazone CAS 122320-73-4 and Pioglitazone CAS 111025-46-8.

PEPCK-M activators are compounds that stimulate the activity or expression of the mitochondrial isoform of phosphoenolpyruvate carboxykinase (PEPCK-M). PEPCK is a critical enzyme involved in gluconeogenesis, the metabolic pathway responsible for the generation of glucose from non-carbohydrate precursors. There are two isoforms of PEPCK: the cytosolic version (PEPCK-C) and the mitochondrial version (PEPCK-M). While PEPCK-C is more traditionally associated with gluconeogenesis, especially in the liver, PEPCK-M plays a role in various tissues, including the kidney and small intestine.

PEPCK-M catalyzes the conversion of oxaloacetate to phosphoenolpyruvate (PEP), a key step in the process of generating glucose. By doing so, it facilitates the movement of carbon substrates between the tricarboxylic acid (TCA) cycle and gluconeogenesis, thus playing a pivotal role in metabolic flexibility and energy homeostasis. PEPCK-M activators, by enhancing the enzyme's activity or expression, can potentiate the flux of metabolites through the gluconeogenic pathway, promoting glucose production from non-carbohydrate sources. Given the importance of PEPCK-M in bridging central carbon metabolism with gluconeogenesis, understanding the mechanisms and implications of PEPCK-M activation offers profound insights into the intricate balance of energy production, especially during periods of fasting or metabolic stress. Delving into the role of PEPCK-M activators provides a comprehensive view of the cellular strategies employed to maintain glucose homeostasis, highlighting the delicate interplay of metabolic pathways in response to varying energy demands and substrate availability.